Characterisation of cloned lines of Trypanosoma brucei expressing stable resistance to MelCy and suramin
- PMID: 8659324
- DOI: 10.1016/0001-706x(96)00131-3
Characterisation of cloned lines of Trypanosoma brucei expressing stable resistance to MelCy and suramin
Abstract
Two cloned drug-sensitive stocks of Trypanosoma brucei (STIB 247 and STIB 386) were each used to generate cloned lines expressing resistance to the melaminophenyl arsenical drug cymelarsan (247MelCyR and 386MelCyR) and to suramin (247SurR and 386SurR). The drug-resistance phenotypes were stable after passaging in mice in the absence of drug pressure and three of the lines were transmitted through tsetse flies with no alteration of drug-resistance. There was no evidence of cross-resistance between melCy and suramin in vivo. Twenty-four hour growth inhibition assays were conducted on bloodstream and procyclic forms in axenic in vitro cultures. Suramin-resistance was expressed in bloodstream forms but not in the procyclic stage, while the melCy-resistant lines expressed melCy-resistance in both stages. No cross-resistance between melCy and suramin was observed. Cross-resistance between melCy and another arsenical drug, melB (melarsoprol), was observed in vivo, but to only a very limited extent in vitro. We propose that this difference between the in vivo and in vitro results for melB may indicate that an alteration in a surface adenosine transporter responsible for reduced melCy uptake was bypassed by melB over 24 hours in vitro.
Similar articles
-
Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.Exp Parasitol. 1997 Jul;86(3):181-90. doi: 10.1006/expr.1997.4167. Exp Parasitol. 1997. PMID: 9225768
-
Induction of resistance to melarsenoxide cysteamine (Mel Cy) in Trypanosoma brucei brucei.Acta Trop. 1994 Dec;58(3-4):187-97. doi: 10.1016/0001-706x(94)90013-2. Acta Trop. 1994. PMID: 7709858
-
In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium.Acta Trop. 1991 Dec;50(2):101-10. doi: 10.1016/0001-706x(91)90002-2. Acta Trop. 1991. PMID: 1685865
-
Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.Parasitol Res. 2003 May;90(1):71-9. doi: 10.1007/s00436-002-0799-9. Epub 2003 Jan 31. Parasitol Res. 2003. PMID: 12743807 Review.
-
The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes.Parasitol Today. 1999 Apr;15(4):136-40. doi: 10.1016/s0169-4758(99)01414-3. Parasitol Today. 1999. PMID: 10322334 Review.
Cited by
-
Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies.Int J Parasitol Drugs Drug Resist. 2024 Aug;25:100533. doi: 10.1016/j.ijpddr.2024.100533. Epub 2024 Mar 30. Int J Parasitol Drugs Drug Resist. 2024. PMID: 38555795 Free PMC article. Review.
-
Systematic Review and Meta-Analysis on Human African Trypanocide Resistance.Pathogens. 2022 Sep 25;11(10):1100. doi: 10.3390/pathogens11101100. Pathogens. 2022. PMID: 36297157 Free PMC article. Review.
-
Antiplasmodial, Antitrypanosomal, and Cytotoxic Effects of Anthonotha macrophylla, Annickia polycarpa, Tieghemella heckelii, and Antrocaryon micraster Extracts.Adv Pharmacol Pharm Sci. 2022 Jul 23;2022:9195753. doi: 10.1155/2022/9195753. eCollection 2022. Adv Pharmacol Pharm Sci. 2022. PMID: 35915745 Free PMC article.
-
In vitro effects and mechanisms of action of Bidens pilosa in Trypanosoma brucei.J Tradit Complement Med. 2021 Aug 11;12(3):260-268. doi: 10.1016/j.jtcme.2021.08.008. eCollection 2022 May. J Tradit Complement Med. 2021. PMID: 35493314 Free PMC article.
-
Laboratory Selection of Trypanosomatid Pathogens for Drug Resistance.Pharmaceuticals (Basel). 2022 Jan 24;15(2):135. doi: 10.3390/ph15020135. Pharmaceuticals (Basel). 2022. PMID: 35215248 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources